Tiantu Capital
VC Fund
Shenzhen, China
Tiantu Capital is a venture capital association.
- Total investments:
- 139
- Last investment:
- Lead investor:
- 52%
- Fund size:
- $68M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Tiantu Capital invests in
Stages Tiantu Capital invests in
Countries Tiantu Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $7M–$20M
- Series A
- $1.4M–$16M
- Series B
- $10M–$142M
Investment Focus
Industry
- Food and Beverage 20 (14%)
- E-Commerce 17 (12%)
- Health Care 14 (10%)
- Medical 13 (9%)
- Artificial Intelligence 12 (9%)
Stage
- Series A 52 (37%)
- Series B 22 (16%)
- Seed 15 (11%)
- Series C 15 (11%)
- Angel 14 (10%)
Country
- China 110 (79%)
- United States 4 (3%)
- Japan 1 (1%)
- Thailand 1 (1%)
- Switzerland 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Li Kanglin
Partner
|
Partner | Total investments: 3 | Find email | |
|
Wu Xianyong
Partner
|
Partner | Total investments: 2 | Find email | |
|
Xu Mengchen
vice president
|
vice president | Total investments: 5 | Find email | |
|
Yonghua Wang
Chairman and President
|
Chairman and President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
DeyeeMed is a globally recognized professional artificial intelligence medical robot company that combines R&D, manufacture, sales, and service training. | Series A / Jul 15, 2026 | |
|
|
GenOptima is an AI-driven digital marketing company that provides generative SEO services. | Seed / Jul 07, 2026 | |
|
|
Keshilifu is a skin care product brand, Keshilifu will use the top raw materials, top factories, and super product power to provide natural organic + functional skin care products for middle and high-end people. | Series A / Jun 06, 2026 | |
|
|
Shuangpai Robotics integrates R&D, Production and sales of age-friendly intelligent devices. | Series A / Apr 08, 2026 | |
|
|
Insight Technology is an instrument manufacturer and seller company that specializes in instrument sales, intelligent instrument sales, mechanical equipment research and development, and more. | Seed / Mar 23, 2026 | |
|
|
Hertz Life Science Technology uses virus-like particle VLPs technology to develop animal and human vaccines.The company has several underlying core patented technologies and has established a stable and efficient research and development platform based on the Jiyin Biomedical Transformation (Greater Bay Area) base, and actively promotes theresearch and development of vaccines.At present, the company has carried out extensive and in-depth cooperation with large enterprises such as Qingdao Yibang and Wen's Group, and its R&D strength has been highly recognized by peers and upstream and downstream enterprises. | Series A / Jan 28, 2026 | |
|
|
Signet Therapeutics is a cutting-edge firm that conducts research and development on cancer-targeted drugs using AI and organoid disease models. | $11.5M / Series A / Jan 14, 2026 | |
|
|
Ruiwei New Materials is a developer of biodegradable materials focused on applying them to the consumer market. It provides end-brand customers with integrated solutions from laboratory research and development to material processing and manufacturing. | Series B / Oct 11, 2025 | |
|
IMCOCO Group
|
IMCOCO Group engaged in the entire coconut water industry chain business, Its business covers four major sectors: the cultivation of aromatic coconuts, cross-border trade of coconut fruits, R & D and production of coconut water raw materials, and the processing of coconut water beverages. | $13.9M / Seed / May 22, 2025 | |
|
|
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment. | Seed / Apr 28, 2025 | |
| See all 139 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tiantu Capital invest in?
Tiantu Capital invests primarily in Food and Beverage, E-Commerce and Health Care startups, most often at Series A and Series B stage. Most of the 139 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Tiantu Capital's check size?
Tiantu Capital typically joins rounds of $7M–$20M at Seed, $1.4M–$16M at Series A and $10M–$142M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tiantu Capital participates in.
How do I contact Tiantu Capital?
Public channels for Tiantu Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Tiantu Capital?
The team at Tiantu Capital includes Li Kanglin (Partner), Wu Xianyong (Partner) and Xu Mengchen (vice president). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!